|
Press Releases |
|
|
|
Wednesday, August 30, 2023 |
|
中旅国际2023年上半年股东应占利润达2.24亿港元,派发中期股息每股1.5港仙 |
香港中旅国际投资有限公司(「中旅国际」或「本公司」,连同其附属公司统称「本集团」)(股份代号:308)今天公布截至2023年6月30日止六个月(「期内」)之中期业绩。 more info >> |
|
中旅國際2023年上半年股東應佔利潤達2.24億港元,派發中期股息每股1.5港仙 |
香港中旅國際投資有限公司(「中旅國際」或「本公司」,連同其附屬公司統稱「本集團」)(股份代號:308)今天公佈截至2023年6月30日止六個月(「期內」)之中期業績。 more info >> |
|
China Travel International's profit attributable to shareholders achieved HK$ 224 million in 1H2023, proposed an interim dividend of HK 1.5 cents per share |
China Travel International Investment Hong Kong Limited ("China Travel International" or the "Company", together with its subsidiaries, the "Group") (stock code: 308) has announced its interim results for the six months ended 30 June 2023 (the "Period"). more info >> |
|
Saturday, April 1, 2023 |
|
中旅国际2022年全年综合收入30.32亿港元 |
香港中旅国际投资有限公司(「中旅国际」或「本公司」,连同其附属公司统称「本集团」)(股份代号:308)公布截至2022年12月31止之经审核全年业绩。 more info >> |
|
中旅國際2022年全年綜合收入30.32億港元 |
香港中旅國際投資有限公司(「中旅國際」或「本公司」,連同其附屬公司統稱「本集團」)(股份代號:308)公佈截至2022年12月31止之經審核全年業績。 more info >> |
|
China Travel International's Consolidated Revenue of HK$3,032 Million in 2022 |
China Travel International Investment Hong Kong Limited ("China Travel International" or the "Company", together with its subsidiaries, the "Group") (Stock Code: 308) announced the audited annual results for the year ended 31 December 2022 (the "Period"). more info >> |
|
Monday, May 13, 2019 |
|
CIFTIS 2019 to Shape a New Pattern in China's Comprehensive Opening-up |
This year's 'Two Sessions' (the National People's Congress, the Chinese People's Political Consultative Conference) sent a positive message to the world that China will deepen reform and expand opening-up. more info >> |
|
Thursday, November 26, 2009 |
|
The Hong Kong Institute of Directors Announces Winners of Directors Of The Year Awards 2009 |
The Hong Kong Institute of Directors announced and honoured winners of the Directors Of The Year Awards ("DOYA") 2009 today at the Annual Dinner of the Institute held at the Hong Kong Convention and Exhibition Centre and attended by more than 500 guests from different industries and sectors. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Combat Holiday Stress and Protect Your Immunity with LAC This Christmas!
Jan 3, 2025 22:55 HKT/SGT
|
|
|
蜜雪冰城擬香港上市 業績如虹釋放飛輪效應
Jan 3, 2025 22:50 HKT/SGT
|
|
|
Galaxy Payroll Group Limited and People Intelligence Singapore Pte. Ltd. Announce Strategic Partnership
Jan 3, 2025 20:41: JST
|
|
|
Galaxy Payroll Group Limited and People Intelligence Singapore Pte. Ltd. Announce Strategic Partnership
Jan 3, 2025 20:41 JST
|
|
|
蜜雪冰城拟香港上市 业绩如虹释放飞轮效应
Jan 3, 2025 16:24 HKT/SGT
|
|
|
Veganuary for Pets
Jan 3, 2025 07:00 HKT/SGT
|
|
|
Asia's Flagship Toy Fair Kicks Off 2025 Trade Shows
Jan 2, 2025 18:37 HKT/SGT
|
|
|
沿著一帶一路賣飲料 雪王已進入海外11國
Jan 2, 2025 17:41 HKT/SGT
|
|
|
沿着一带一路卖饮料 雪王已进入海外11国
Jan 2, 2025 17:29 HKT/SGT
|
|
|
SPRG Steps Confidently into its 30th Year of Development
Jan 2, 2025 16:58 HKT/SGT
|
|
|
纵横公关集团成立30周年 昂首迈向璀璨新里程
Jan 2, 2025 16:41 HKT/SGT
|
|
|
縱橫公關集團成立30周年 昂首邁向璀璨新里程
Jan 2, 2025 14:26 HKT/SGT
|
|
|
Everest Medicines Announces the Implementation of NEFECON National Reimbursement Drug List Pricing in China for the Treatment for IgA Nephropathy
Jan 2, 2025 10:52 HKT/SGT
|
|
|
新版國家醫保藥品目錄落地 全球首個IgA腎病對因治療藥物耐賦康(R)納入報銷
Jan 2, 2025 10:52 HKT/SGT
|
|
|
新版国家医保药品目录落地 全球首个IgA肾病对因治疗药物耐赋康(R)纳入报销
Jan 2, 2025 10:48 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|